Novartis AG
USE OF RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS
Last updated:
Abstract:
The present invention relates to therapeutic uses of compounds of formula (I) or a pharmaceutically acceptable salt thereof ##STR00001##
Status:
Application
Type:
Utility
Filling date:
28 Feb 2019
Issue date:
1 Aug 2019